ProCE Banner Activity

Expert Guidance on the Evolving Therapeutic Landscape for HER2-Positive Early-Stage Breast Cancer: Slides

Slideset Download
Download these expert-selected slides on optimal treatment for patients with HER2-positive early breast cancer.

Released: February 02, 2021

Expiration: February 01, 2022

No longer available for credit.

Share

Faculty

Jame Abraham

Jame Abraham, MD, FACP

Chairman
Department of Hematology and Medical Oncology
Taussig Cancer Institute
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Cleveland Clinic
Cleveland, Ohio

Provided by

Provided by National Comprehensive Cancer Network, in partnership with Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Genentech, a member of the Roche Group

Puma Biotechnology, Inc.

Faculty Disclosure

Primary Author

Jame Abraham, MD, FACP

Chairman
Department of Hematology and Medical Oncology
Taussig Cancer Institute
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Cleveland Clinic
Cleveland, Ohio